Delta 9 Receives Conditional Approval to List on TSX

Published: August 12, 2019

Delta 9 Receives Conditional Approval to List on TSX

Delta 9 Cannabis Inc. has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange (“TSXV”) and list its common shares (the “Common Shares”), Common Share purchase warrants expiring December 28, 2019 (the “2017 Warrants”), Common Share purchase warrants expiring July 17, 2022 (the “2019 Warrants”) and 8.5% unsecured convertible debentures on the TSX.

“We are very excited to be in the final stages of qualifying to be up listed to the TSX. This is a major milestone in our strategic growth plan and for our shareholders,” said John Arbuthnot, Chief Executive Officer of Delta 9. “This eventual listing on the TSX will help to increase trading liquidity, provide access a growing investor base interested in the cannabis industry, and raise capital for further investments.”

Final approval of the listing is subject to the Company meeting certain standard requirements of the TSX on or before November 5, 2019. The Company expects to satisfy all of the requirements and will make a further announcement once the TSX has issued a bulletin confirming the date on which trading on the TSX will commence. Upon completion of the final listing requirements, the Common Shares, 2017 Warrants, 2019 Warrants and Debentures will be delisted from the TSXV and begin trading on the TSX under the symbols, “DN”, “DN.WT”, “DN.WT.A” and “DN.DB”, respectively.

“As one of Canada’s only vertically integrated cannabis companies, we are excited about the opportunities in this rapidly growing market to drive shareholder value and continue Delta 9’s success story,” said John Arbuthnot, Chief Executive Officer of Delta 9. “The TSX is the premier listings destination and this achievement highlights the strength of our experienced management and team, our commitment to growing shareholder value.”

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada.

Recent News

View All News Items

Latest Article

Artificial Intelligence, Learning and Explosive Growth in Cannabis

Artificial Intelligence, Learning and Explosive Growth in Cannabis

Organizations operating in the industry have a distinct need for clear communication across multiple departments and sophisticated ways of training new employees quickly to ensure compliance, efficiency and more. Companies looking to grow and capitalize need to be agile and have the ability to train employees on the latest information necessary for success.

Read Article